Study 8 of 12Retatrutide (LY3437943) literatureBMJ (Clinical research ed.)Top journal2026
Retatrutide: Obesity drug opens to "compassionate use" in US after speculation Trump took it.
Not reported in abstract.
Where it sits
this study against the rest of the retatrutide (ly3437943) corpus5
Preclinical · this one
2
Observational
0
Open-label
1
Randomised
4
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Retatrutide (LY3437943) corpus
BAccelerating Use of Unapproved Retatrutide Is Associated with Weaker Weight Loss and Increased Cardiovascular Symptomsbiorxiv-preprint · 2026 · 7.2% body weight loss at 6-12 months for compounded retatrutide users, n=531, P=0.004.HumanARetatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes.Diabetes, obesity & metabolism · 2023 · High-sensitivity C-reactive protein was reduced by -54.8% in Study 2.HumanDGLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation.Current psychiatry reports · 2023 · Not reported in abstract.reviewCEffects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats.Behavioural brain research · 2026 · Not reported in abstract.AnimalDRetatrutide: Obesity drug opens to "compassionate use" in US after speculation Trump took it.BMJ (Clinical research ed.) · 2026—CEffects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats.Behavioural brain research · 2026 · Retatrutide-treated diabetic rats showed preserved overall Morris Water Maze performance relative to untreated diabetic rats.Animal